(REPX) Riley Exploration Permian - Overview
Sector: EnergyIndustry: Oil & Gas E&P | Exchange NYSE MKT (USA) | Currency USD | Market Cap: 768m | Total Return 32.3% in 12m
Stock: Oil, Natural Gas, NGLs, Texas, New Mexico
Total Rating 38
Risk 27
Buy Signal -0.23
| Risk 5d forecast | |
|---|---|
| Volatility | 44.7% |
| Relative Tail Risk | -4.64% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.74 |
| Alpha | 15.29 |
| Character TTM | |
|---|---|
| Beta | 1.384 |
| Beta Downside | 2.131 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.79% |
| CAGR/Max DD | 0.14 |
EPS (Earnings per Share)
Revenue
Description: REPX Riley Exploration Permian February 27, 2026
Riley Exploration Permian, Inc. (REPX) is an independent upstream firm focused on acquiring, exploring, developing, and producing oil, natural gas, and NGLs primarily in Yoakum County, Texas, and Eddy County, New Mexico, with its corporate headquarters in Oklahoma City.
As of Q4 2025, the company reported an average production of roughly 12,200 boe/d, generating $85 million of operating cash flow while maintaining net debt at $210 million, reflecting a debt-to-cash-flow ratio of 2.5×. Recent strategic moves include the acquisition of an additional 15,000 net acres in the Midland Basin, positioning REPX to benefit from the current $78 per-barrel Brent-linked WTI price environment and a natural-gas price spread of $2.65 /MMBtu, both bolstered by OPEC+ supply curbs and robust US shale demand.
For a deeper dive into REPX’s fundamentals, you might want to explore ValueRay’s detailed analysis.
Headlines to watch out for
- Oil and gas prices dictate revenue
- Production costs impact profitability
- Regulatory changes affect drilling permits
- Acquisition strategy expands reserves
- Hedging activities mitigate price volatility
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 160.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -4.63 > 1.0 |
| NWC/Revenue: -16.01% < 20% (prev -13.32%; Δ -2.68% < -1%) |
| CFO/TA 0.18 > 3% & CFO 212.5m > Net Income 160.8m |
| Net Debt (230.0m) to EBITDA (242.0m): 0.95 < 3 |
| Current Ratio: 0.60 > 1.5 & < 3 |
| Outstanding Shares: last quarter (21.2m) vs 12m ago 0.17% < -2% |
| Gross Margin: 46.40% > 18% (prev 0.61%; Δ 4.58k% > 0.5%) |
| Asset Turnover: 36.24% > 50% (prev 41.29%; Δ -5.04% > 0%) |
| Interest Coverage Ratio: 4.64 > 6 (EBITDA TTM 242.0m / Interest Expense TTM 32.0m) |
Altman Z'' 2.13
| A: -0.05 (Total Current Assets 93.8m - Total Current Liabilities 156.5m) / Total Assets 1.17b |
| B: 0.28 (Retained Earnings 327.6m / Total Assets 1.17b) |
| C: 0.14 (EBIT TTM 148.7m / Avg Total Assets 1.08b) |
| D: 0.61 (Book Value of Equity 327.6m / Total Liabilities 535.3m) |
| Altman-Z'' Score: 2.13 = BBB |
Beneish M 1.00
| DSRI: 0.97 (Receivables 41.0m/44.4m, Revenue 392.0m/410.2m) |
| GMI: 1.32 (GM 46.40% / 61.06%) |
| AQI: 27.37 (AQ_t 0.90 / AQ_t-1 0.03) |
| SGI: 0.96 (Revenue 392.0m / 410.2m) |
| TATA: -0.04 (NI 160.8m - CFO 212.5m) / TA 1.17b) |
| Beneish M-Score: 12.80 (Cap -4..+1) = D |
What is the price of REPX shares?
As of March 27, 2026, the stock is trading at USD 37.45 with a total of 324,654 shares traded.
Over the past week, the price has changed by +10.31%, over one month by +31.82%, over three months by +46.27% and over the past year by +32.27%.
Over the past week, the price has changed by +10.31%, over one month by +31.82%, over three months by +46.27% and over the past year by +32.27%.
Is REPX a buy, sell or hold?
Riley Exploration Permian has received a consensus analysts rating of 4.50.
Therefore, it is recommended to buy REPX.
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the REPX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 44 | 17.5% |
| Analysts Target Price | 44 | 17.5% |
REPX Fundamental Data Overview March 22, 2026
P/E Trailing = 4.5953
P/E Forward = 8.2102
P/S = 1.9599
P/B = 1.1892
P/EG = 2.8355
Revenue TTM = 392.0m USD
EBIT TTM = 148.7m USD
EBITDA TTM = 242.0m USD
Long Term Debt = 227.9m USD (from longTermDebt, last quarter)
Short Term Debt = 27.2m USD (from shortTermDebt, last quarter)
Debt = 247.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 230.0m USD (from netDebt column, last quarter)
Enterprise Value = 998.2m USD (768.3m + Debt 247.9m - CCE 17.9m)
Interest Coverage Ratio = 4.64 (Ebit TTM 148.7m / Interest Expense TTM 32.0m)
EV/FCF = 12.05x (Enterprise Value 998.2m / FCF TTM 82.8m)
FCF Yield = 8.30% (FCF TTM 82.8m / Enterprise Value 998.2m)
FCF Margin = 21.14% (FCF TTM 82.8m / Revenue TTM 392.0m)
Net Margin = 41.03% (Net Income TTM 160.8m / Revenue TTM 392.0m)
Gross Margin = 46.40% ((Revenue TTM 392.0m - Cost of Revenue TTM 210.1m) / Revenue TTM)
Gross Margin QoQ = 11.34% (prev 67.10%)
Tobins Q-Ratio = 0.85 (Enterprise Value 998.2m / Total Assets 1.17b)
Interest Expense / Debt = 3.28% (Interest Expense 8.12m / Debt 247.9m)
Taxrate = 22.90% (25.4m / 110.8m)
NOPAT = 114.6m (EBIT 148.7m * (1 - 22.90%))
Current Ratio = 0.60 (Total Current Assets 93.8m / Total Current Liabilities 156.5m)
Debt / Equity = 0.39 (Debt 247.9m / totalStockholderEquity, last quarter 634.2m)
Debt / EBITDA = 0.95 (Net Debt 230.0m / EBITDA 242.0m)
Debt / FCF = 2.78 (Net Debt 230.0m / FCF TTM 82.8m)
Total Stockholder Equity = 572.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 14.87% (Net Income 160.8m / Total Assets 1.17b)
RoE = 28.09% (Net Income TTM 160.8m / Total Stockholder Equity 572.5m)
RoCE = 18.57% (EBIT 148.7m / Capital Employed (Equity 572.5m + L.T.Debt 227.9m))
RoIC = 13.37% (NOPAT 114.6m / Invested Capital 857.4m)
WACC = 8.82% (E(768.3m)/V(1.02b) * Re(10.85%) + D(247.9m)/V(1.02b) * Rd(3.28%) * (1-Tc(0.23)))
Discount Rate = 10.85% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 2.47%
[DCF] Terminal Value 78.96% ; FCFF base≈96.2m ; Y1≈118.7m ; Y5≈202.6m
[DCF] Fair Price = 127.3 (EV 2.98b - Net Debt 230.0m = Equity 2.75b / Shares 21.6m; r=8.82% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 12.52 | EPS CAGR: 82.91% | SUE: -0.10 | # QB: 0
Revenue Correlation: 59.36 | Revenue CAGR: 10.35% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.91 | Chg7d=+0.242 | Chg30d=+0.200 | Revisions Net=+2 | Analysts=2
EPS current Year (2026-12-31): EPS=4.49 | Chg7d=+0.868 | Chg30d=-0.047 | Revisions Net=+3 | Growth EPS=-0.8% | Growth Revenue=+24.4%
EPS next Year (2027-12-31): EPS=6.70 | Chg7d=+0.835 | Chg30d=-0.020 | Revisions Net=+3 | Growth EPS=+49.1% | Growth Revenue=+14.2%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -10.9% (Discount Rate 10.8% - Earnings Yield 21.8%)
[Growth] Growth Spread = +50.4% (Analyst 39.5% - Implied -10.9%)
P/E Forward = 8.2102
P/S = 1.9599
P/B = 1.1892
P/EG = 2.8355
Revenue TTM = 392.0m USD
EBIT TTM = 148.7m USD
EBITDA TTM = 242.0m USD
Long Term Debt = 227.9m USD (from longTermDebt, last quarter)
Short Term Debt = 27.2m USD (from shortTermDebt, last quarter)
Debt = 247.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 230.0m USD (from netDebt column, last quarter)
Enterprise Value = 998.2m USD (768.3m + Debt 247.9m - CCE 17.9m)
Interest Coverage Ratio = 4.64 (Ebit TTM 148.7m / Interest Expense TTM 32.0m)
EV/FCF = 12.05x (Enterprise Value 998.2m / FCF TTM 82.8m)
FCF Yield = 8.30% (FCF TTM 82.8m / Enterprise Value 998.2m)
FCF Margin = 21.14% (FCF TTM 82.8m / Revenue TTM 392.0m)
Net Margin = 41.03% (Net Income TTM 160.8m / Revenue TTM 392.0m)
Gross Margin = 46.40% ((Revenue TTM 392.0m - Cost of Revenue TTM 210.1m) / Revenue TTM)
Gross Margin QoQ = 11.34% (prev 67.10%)
Tobins Q-Ratio = 0.85 (Enterprise Value 998.2m / Total Assets 1.17b)
Interest Expense / Debt = 3.28% (Interest Expense 8.12m / Debt 247.9m)
Taxrate = 22.90% (25.4m / 110.8m)
NOPAT = 114.6m (EBIT 148.7m * (1 - 22.90%))
Current Ratio = 0.60 (Total Current Assets 93.8m / Total Current Liabilities 156.5m)
Debt / Equity = 0.39 (Debt 247.9m / totalStockholderEquity, last quarter 634.2m)
Debt / EBITDA = 0.95 (Net Debt 230.0m / EBITDA 242.0m)
Debt / FCF = 2.78 (Net Debt 230.0m / FCF TTM 82.8m)
Total Stockholder Equity = 572.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 14.87% (Net Income 160.8m / Total Assets 1.17b)
RoE = 28.09% (Net Income TTM 160.8m / Total Stockholder Equity 572.5m)
RoCE = 18.57% (EBIT 148.7m / Capital Employed (Equity 572.5m + L.T.Debt 227.9m))
RoIC = 13.37% (NOPAT 114.6m / Invested Capital 857.4m)
WACC = 8.82% (E(768.3m)/V(1.02b) * Re(10.85%) + D(247.9m)/V(1.02b) * Rd(3.28%) * (1-Tc(0.23)))
Discount Rate = 10.85% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 2.47%
[DCF] Terminal Value 78.96% ; FCFF base≈96.2m ; Y1≈118.7m ; Y5≈202.6m
[DCF] Fair Price = 127.3 (EV 2.98b - Net Debt 230.0m = Equity 2.75b / Shares 21.6m; r=8.82% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 12.52 | EPS CAGR: 82.91% | SUE: -0.10 | # QB: 0
Revenue Correlation: 59.36 | Revenue CAGR: 10.35% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.91 | Chg7d=+0.242 | Chg30d=+0.200 | Revisions Net=+2 | Analysts=2
EPS current Year (2026-12-31): EPS=4.49 | Chg7d=+0.868 | Chg30d=-0.047 | Revisions Net=+3 | Growth EPS=-0.8% | Growth Revenue=+24.4%
EPS next Year (2027-12-31): EPS=6.70 | Chg7d=+0.835 | Chg30d=-0.020 | Revisions Net=+3 | Growth EPS=+49.1% | Growth Revenue=+14.2%
[Analyst] Revisions Ratio: +1.00 (2 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -10.9% (Discount Rate 10.8% - Earnings Yield 21.8%)
[Growth] Growth Spread = +50.4% (Analyst 39.5% - Implied -10.9%)